Protective effects of safranal on hypoxia/reoxygenation-induced injury in H9c2 cardiac myoblasts via the PI3K/AKT/GSK3β signaling pathway

被引:8
|
作者
Wang, Hefei [1 ]
Zheng, Bin [2 ]
Che, Kaimeng [1 ]
Han, Xue [1 ]
Li, Li [3 ]
Wang, Hongfang [2 ]
Liu, Yanshuang [4 ]
Shi, Jing [5 ]
Sun, Shijiang [6 ]
机构
[1] Hebei Univ Chinese Med, Sch Basic Med, Dept Tradit Chinese Med & Med Hist Literat, Shijiazhuang, Hebei, Peoples R China
[2] Hebei Univ Chinese Med, Sch Pharm, Dept Tradit Chinese Med, Shijiazhuang, Hebei, Peoples R China
[3] Hebei Med Univ, Sch Pharm, Dept Pharmacognosy, Shijiazhuang, Hebei, Peoples R China
[4] Hebei Univ Chinese Med, Coll Integrat Med, Hebei Key Lab Integrat Med Liver Kidney Patterns, Inst Integrat Med,Dept Diagnost, Shijiazhuang 050200, Hebei, Peoples R China
[5] Fourth Hosp Hebei Med Univ, Dept Sci Res Management, 12 Jiankang Rd, Shijiazhuang 050011, Hebei, Peoples R China
[6] Hebei Univ Chinese Med, Affiliated Hosp 1, Hebei Prov Hosp Chinese Med, Dept Hosp Management & Med Hist Literature, 389 Zhongshan East Rd, Shijiazhuang 050200, Hebei, Peoples R China
关键词
safranal; H9c2 cardiac myoblasts; anti-oxidant stress; hypoxia/reoxygenation; anti-apoptosis; PI3K/AKT/GSK3 beta signaling pathway; ISCHEMIA-REPERFUSION INJURY; MITOCHONDRIAL PERMEABILITY TRANSITION; CROCUS-SATIVUS L; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION-INJURY; ACTIVE CONSTITUENT; INDUCED APOPTOSIS; HYDROGEN-SULFIDE; SAFFRON EXTRACT;
D O I
10.3892/etm.2021.10836
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Safranal (SFR), an active ingredient extracted from saffron, exhibits a protective effect on the cardiovascular system. However, the mechanism of SFR against hypoxia/reoxygenation (H/ R)-induced cardiomyocyte injury has previously not been investigated in vitro. The aim of the present study was therefore to observe the protective effects of SFR on H/R-induced cardiomyocyte injury and to explore its mechanisms. A H/ R injury model of H9c2 cardiac myoblasts was established by administering 800 mu mol/l CoCl2 to H9c2 cells for 24 h and reoxygenating the cells for 4 h to induce hypoxia. H9c2 cardiac myoblasts were pretreated with SFR for 12 h to evaluate the associated protective effects. A Cell Counting Kit-8 assay was used for cell viability detection, and the expression levels of lactate dehydrogenase (LDH), creatine kinase-MB (CK-MB), glutathione peroxidase (GSH-px), catalase (CAT), superoxide dismutase (SOD), malondialdehyde (MDA) and caspase-3, and the intracellular Ca2+ concentration were measured using the corresponding commercial kits. Levels of reactive oxygen species (ROS) in the cells were detected using 2,7-dichlorodihydrofluorescein diacetate. Flow cytometry was used to determine the degree of apoptosis and the level of mitochondrial membrane potential (MMP). Moreover, the expression levels of phosphorylated (p-)PI3K, AKT, p-AKT, glycogen synthase kinase 3 beta (GSK3 beta), p-GSK3 beta, Bcl-2, Bax, caspase-3 and cleaved caspase-3 were measured using western blot analysis. Results of the present study demonstrated that the H9c2 cardiac myoblasts treated with SFR exhibited significantly improved levels of viability and significantly reduced levels of ROS, compared with the H/ R group. Furthermore, compared with the H/ R group, SFR treatment significantly increased the MMP levels and antioxidant enzyme levels, including CAT, SOD and GSH-px; whereas the levels of CK-MB, LDH, MDA and intracellular Ca2+ concentration were significantly decreased. Moreover, the results of the present study demonstrated that SFR significantly reduced caspase-3, cleaved caspase-3 and Bax protein expression levels, but upregulated the Bcl-2 protein expression levels. SFR also increased the protein expressions of PI3K/AKT/GSK3 beta. In summary, the results suggested that SFR may exert a protective effect against H/R-induced cardiomyocyte injury, which occurs in connection with the inhibition of oxidative stress and apoptosis via regulation of the PI3K/AKT/GSK3 beta signaling pathway.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Protective effects of Myrica rubra flavonoids against hypoxia/reoxygenation-induced cardiomyocyte injury via the regulation of the PI3K/Akt/GSK3β pathway
    Wang, Min
    Liu, Ying
    Pan, Rui-Le
    Wang, Rui-Ying
    Ding, Shi-Lan
    Dong, Wan-Rui
    Sun, Gui-Bo
    Ye, Jing-Xue
    Sun, Xiao-Bo
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2019, 43 (05) : 2133 - 2143
  • [2] Knockdown of Tripartite Motif 8 Protects H9C2 Cells Against Hypoxia/Reoxygenation-Induced Injury Through the Activation of PI3K/Akt Signaling Pathway
    Dang, Xiaoyan
    Qin, Yong
    Gu, Changwei
    Sun, Jiangli
    Zhang, Rui
    Peng, Zhuo
    CELL TRANSPLANTATION, 2020, 29
  • [3] Ivabradine Attenuates Hypoxia/Reoxygenation-Induced Excessive Autophagy in H9c2 Cardiomyocyte by Modulation of the PI3K/Akt/mTOR Pathway
    Min Yang
    Hui Li
    Wu Jiatian
    Hua Tianfeng
    CIRCULATION, 2021, 144
  • [4] Shikonin protects H9C2 cardiomyocytes against hypoxia/reoxygenation injury through activation of PI3K/Akt signaling pathway
    Wang, Shuang
    Zhu, Yanfang
    Qiu, Ruixia
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 104 : 712 - 717
  • [5] miR-496 remedies hypoxia reoxygenation-induced H9c2 cardiomyocyte apoptosis via Hook3-targeted PI3k/Akt/mTOR signaling pathway activation
    Jin, Yongping
    Ni, Shimao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (01) : 698 - 712
  • [6] Aqueous extract of Cortex Dictamni protects H9c2 cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress and apoptosis by PI3K/Akt signaling pathway
    Li, Lin
    Zhou, Yunfeng
    Li, Yanlin
    Wang, Lili
    Sun, Lan
    Zhou, Lidong
    Arai, Hiderori
    Qi, Yun
    Xu, Yang
    BIOMEDICINE & PHARMACOTHERAPY, 2017, 89 : 233 - 244
  • [7] Oxymatrine pretreatment protects H9c2 cardiomyocytes from hypoxia/reoxygenation injury by modulating the PI3K/Akt pathway
    Zhang, Zhongbai
    Qin, Xueting
    Wang, Zhenghui
    Li, Yanchun
    Chen, Fei
    Chen, Rundu
    Li, Chuang
    Zhang, Wencheng
    Zhang, Mei
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2021, 21 (06)
  • [8] Pretreatment of ghrelin protects H9c2 cells against hypoxia/reoxygenation-induced cell death via PI3K/AKT and AMPK pathways
    Chen, Yanbo
    Wang, Honggang
    Zhang, Yong
    Wang, Zhengping
    Liu, Shanshan
    Cui, Lianqun
    ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 2179 - 2187
  • [9] Astragaloside IV Regulates the PI3K/Akt/HO-1 Signaling Pathway and Inhibits H9c2 Cardiomyocyte Injury Induced by Hypoxia-Reoxygenation
    Yang, Ping
    Zhou, Yuping
    Xia, Qing
    Yao, Lipeng
    Chang, Xiuchun
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2019, 42 (05) : 721 - 727
  • [10] The protective effects of total paeony glycoside on ischemia/reperfusion injury in H9C2 cells via inhibition of the PI3K/Akt signaling pathway
    Shen, Peihong
    Chen, Junfeng
    Pan, Min
    MOLECULAR MEDICINE REPORTS, 2018, 18 (03) : 3332 - 3340